Publication | Open Access

Apigenin-rivastigmine hybrids as multi-target-directed liagnds for the treatment of Alzheimer’s disease

Multi-target-directed LiagndsNeurodegenerative DiseasesDrug TargetAlzheimer's DiseaseDrug TargetingMedicineApigenin-rivastigmine HybridsAlzheimer ’PharmacotherapyNeurologyDrug DevelopmentPharmacologyNovel TherapyDrug Discovery